Results 171 to 180 of about 60,035 (201)

9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea

Lancet, The, 2022
Ju Sang Kim, Byung Woo Jhun, Kyung-Wook Jo   +2 more
exaly  

Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis

New England Journal of Medicine, 2022
Francesca Conradie, Pauline Howell, Conor D Tweed   +2 more
exaly  

Linezolid

2022
openaire   +1 more source

Linezolid

Reactions Weekly, 2007
openaire   +2 more sources

Linezolid

Reactions Weekly, 2023
openaire   +1 more source

Linezolid

Reactions Weekly, 2019
  +4 more sources

Linezolid

Reactions Weekly, 2016
openaire   +2 more sources

Linezolid

Reactions Weekly
  +5 more sources

Linezolid

Reactions Weekly, 2006
openaire   +1 more source

Linezolid resistance in a clinical isolate of Staphylococcus aureus

Lancet, The, 2001
Sotirios Tsiodras
exaly